Inventor
Yi Zang
Inventor
Princeton Junction, NJ, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds19%
PatentTitleYear
10,239,863Factor XIa inhibitors201910,081,617Factor XIa inhibitors20189,446,021'Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof'20169,353,101'Cyclic amine substituted heterocyclic CETP inhibitors'20169,120,754'Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof'20158,742,110'Spiroxazolidinone compounds'20148,129,519'Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2015Patents assigned to ZANG YI (3)· patent assignee history
2012–2015Patents assigned to CHELLAPPAN SHEELA (2)· patent assignee history
2012–2015Patents assigned to CHOLODY WIESLAW M (2)· patent assignee history
2012–2019Based in Princeton Junction, NJ, US· patent location history
2014–2019Patents assigned to MERCK SHARP & DOHME (4)· patent assignee history
2014Based in Princeton, NJ, US· patent location history
2015–2016Patents assigned to DOGWOOD PHARMACEUTICALS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 4 | 2014–2019 |
| ZANG YIself | 3 | 2012–2015 |
| CHELLAPPAN SHEELA | 2 | 2012–2015 |
| CHOLODY WIESLAW M | 2 | 2012–2015 |
| DOGWOOD PHARMACEUTICALS INC | 2 | 2015–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Princeton Junction, New Jersey, US | 6 | 2012–2019 |
| Princeton, New Jersey, US | 1 | 2014 |